Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junzhe Yi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Genetics & Genomic Medicine|February 25, 2020
Waist circumference increases risk of coronary heart disease: Evidence from a Mendelian randomization studyQinchang Chen, Lingling Li, Junzhe Yi, et al.
Oncology Research|June 3, 2024
CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expressionJunzhe Yi, Binbin Li, Xiaomin Yin, et al.
Brain, Behavior, and Immunity|December 12, 2024
Dysfunction in neuro-mesenchymal units impairs the development of bone marrow B cells in mice with anxietyHeshe Li, Junzhe Yi, Xinghao Xu, et al.
Nature Communications|November 17, 2023
Mesenchymal stromal cells alleviate depressive and anxiety-like behaviors via a lung vagal-to-brain axis in male miceJing Huang, Weijun Huang, Junzhe Yi, et al.
Nature Communications|May 18, 2026
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope studyJunzhe Yi, Jiongliang Wang, Yimin Zhang, et al.
Hepatology International|February 11, 2025
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombusSuixing Zhong, Junzhe Yi, Song Chen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Genetics & Genomic Medicine|February 25, 2020
Waist circumference increases risk of coronary heart disease: Evidence from a Mendelian randomization studyQinchang Chen, Lingling Li, Junzhe Yi, et al.
Oncology Research|June 3, 2024
CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expressionJunzhe Yi, Binbin Li, Xiaomin Yin, et al.
Brain, Behavior, and Immunity|December 12, 2024
Dysfunction in neuro-mesenchymal units impairs the development of bone marrow B cells in mice with anxietyHeshe Li, Junzhe Yi, Xinghao Xu, et al.
Nature Communications|November 17, 2023
Mesenchymal stromal cells alleviate depressive and anxiety-like behaviors via a lung vagal-to-brain axis in male miceJing Huang, Weijun Huang, Junzhe Yi, et al.
Nature Communications|May 18, 2026
Durvalumab plus HAIC-FOLFOX followed by maintenance durvalumab for hepatocellular carcinoma with major portal invasion: phase 2 DurHope studyJunzhe Yi, Jiongliang Wang, Yimin Zhang, et al.
Hepatology International|February 11, 2025
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombusSuixing Zhong, Junzhe Yi, Song Chen, et al.
Pageof 1